Table 1.
Ligand Competing for (—)-[125I]Iodopindolol Binding |
||||||
---|---|---|---|---|---|---|
ICI-118,551 |
ICI-89,406 |
|||||
Young | Old | P value | Young | Old | P value | |
RH, fmol/mg | 2.34 ± 0.82 | 7.17 ± 2.85 | 0.165 | 2.30 ± 0.30 | 3.24 ± 1.12 | 0.450 |
RL, fmol/mg | 1.90 ± 0.33 | 2.83 ± 0.83 | 0.346 | 2.48 ± 0.83 | 3.73 ± 1.11 | 0.399 |
%RH | 51.7 ± 5.8 | 68.1 ± 2.9 | 0.064 | 53.8 ± 11.5 | 44.3 ± 3.0 | 0.478 |
%RL | 48.3 ± 5.8 | 31.9 ± 2.9 | 0.064 | 46.2 ± 11.5 | 55.7 ± 3.0 | 0.478 |
KH, nM | 2.13 ± 1.31 | 9.05 ± 5.80 | 0.309 | 0.50 ± 0.09 | 0.86 ± 0.49 | 0.528 |
KL, µM | 1.14 ± 0.76 | 12.97 ± 9.13 | 0.266 | 7.55 ± 6.19 | 3.72 ± 0.46 | 0.581 |
Values are means ± SE from 4 young and 5 old rats. RH and RL, nos. of sites binding ICI-118,551 or ICI-89,406 with high and low affinity; KH and KL, dissociation constants of high- and low-affinity binding sites. Competition binding curves using liver particulate preparations from young (3–6 mo old) and old (24 mo old) rats were constructed as described in Fig. 2, and the data were analyzed with a weighted, nonlinear, least-squares curve-fitting program (38). ICI-118,551 and ICI-89,406 competition curves were best fit by a 2-site model describing high- and low-affinity binding sites.